Jacobson Pharma Corporation Limited
HKEX:2633.HK
0.75 (HKD) • At close November 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 411.937 | 1,036.418 | 478.653 | 480.35 | 417.993 | 629.842 | 656.733 | 359.685 | 82.925 | 70.258 | 131.492 |
| Short Term Investments
| 46.236 | 52.104 | 51.426 | 43.061 | 7.687 | 59.496 | 47.88 | 44.394 | 40.445 | 35.285 | 29.352 |
| Cash and Short Term Investments
| 411.937 | 1,036.418 | 478.653 | 480.35 | 425.68 | 689.338 | 704.613 | 404.079 | 123.37 | 70.258 | 131.492 |
| Net Receivables
| 172.834 | 288.231 | 0 | 0 | 199.911 | 214.185 | 197.41 | 154.314 | 108.055 | 110.12 | 110.316 |
| Inventory
| 317.857 | 368.003 | 314.557 | 356.184 | 371.456 | 333.831 | 316.323 | 261.313 | 196.915 | 169.087 | 160.368 |
| Other Current Assets
| 61.788 | 12.657 | 0 | 0 | 173.329 | 66.149 | 71.216 | 58.6 | 112.094 | 44.57 | 58.704 |
| Total Current Assets
| 964.416 | 1,757.413 | 1,178.245 | 1,160.782 | 1,170.376 | 1,244.007 | 1,241.682 | 833.912 | 499.989 | 394.035 | 444.94 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 1,301.425 | 1,502.148 | 1,519.055 | 1,565.881 | 1,238.133 | 1,103.919 | 1,030.311 | 1,056.511 | 866.741 | 663.984 | 467.569 |
| Goodwill
| 183.722 | 450.565 | 444.26 | 444.26 | 412.021 | 390.816 | 390.816 | 355.13 | 108.507 | 108.507 | 108.507 |
| Intangible Assets
| 252.127 | 1,320.075 | 1,303.177 | 1,345.075 | 1,310.88 | 649.485 | 672.442 | 690.767 | 312.645 | 314.417 | 264.41 |
| Goodwill and Intangible Assets
| 435.849 | 1,770.64 | 1,747.437 | 1,789.335 | 1,722.901 | 1,040.301 | 1,063.258 | 1,045.897 | 421.152 | 422.924 | 372.917 |
| Long Term Investments
| 679.297 | 750.939 | 701.501 | 727.34 | 850.728 | 404.072 | 130.321 | 2,099.985 | 1,286.424 | 0 | 0 |
| Tax Assets
| 10.853 | 10.231 | 10.156 | 10.263 | 10.083 | 5.976 | 4.191 | 2.423 | 1.469 | 3.49 | 3.3 |
| Other Non-Current Assets
| 95.014 | -410.872 | -400.854 | -386.451 | -412.021 | -5.976 | -4.191 | -2,102.408 | -1,287.893 | 220.778 | 168.083 |
| Total Non-Current Assets
| 2,522.438 | 3,623.086 | 3,577.295 | 3,706.368 | 3,409.824 | 2,548.292 | 2,223.89 | 2,102.408 | 1,287.893 | 1,311.176 | 1,011.869 |
| Total Assets
| 3,486.854 | 5,380.499 | 4,755.54 | 4,867.15 | 4,580.2 | 4,260.594 | 3,611.155 | 2,970.067 | 1,822.05 | 1,705.211 | 1,456.809 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 51.688 | 80.245 | 50.46 | 38.59 | 36.018 | 40.458 | 35.188 | 40.894 | 26.303 | 24.679 | 29.605 |
| Short Term Debt
| 139.672 | 344.377 | 646.148 | 721.85 | 586.104 | 925.543 | 1,351.153 | 937.635 | 476.229 | 531.072 | 331.87 |
| Tax Payables
| 16.704 | 28.405 | 20.825 | 14.334 | 10.347 | 11.896 | 4.657 | 12.713 | 11.221 | 2.614 | 8.641 |
| Deferred Revenue
| 0 | 54.885 | 3.74 | 3.43 | 6.543 | 5.338 | -1,351.153 | 3.155 | -440.027 | 2.614 | 8.641 |
| Other Current Liabilities
| 164.779 | 148.523 | 105.211 | 95.702 | 88.348 | 71.136 | 70.365 | 64.092 | 303.082 | 89.259 | 118.798 |
| Total Current Liabilities
| 372.843 | 656.435 | 826.384 | 873.906 | 727.36 | 1,054.371 | 1,461.363 | 1,058.489 | 816.835 | 650.238 | 488.914 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 609.707 | 1,254.687 | 763.791 | 926.773 | 1,062.024 | 371.723 | 0.66 | 0.373 | 0.522 | 0.867 | 6.54 |
| Deferred Revenue Non-Current
| 0 | 1,254.687 | 763.791 | 926.773 | 1,062.024 | 223.885 | -141.157 | -138.887 | 0 | -47.471 | 3.568 |
| Deferred Tax Liabilities Non-Current
| 107.944 | 212.855 | 207.4 | 206.362 | 184.723 | 147.362 | 141.157 | 138.887 | 48.548 | 47.471 | 44.368 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 717.651 | 1,467.542 | 971.191 | 1,133.135 | 1,246.747 | 371.247 | 141.817 | 139.26 | 49.07 | 48.338 | 50.908 |
| Total Liabilities
| 1,090.494 | 2,123.977 | 1,797.575 | 2,007.041 | 1,974.107 | 1,573.456 | 1,603.18 | 1,197.749 | 865.905 | 698.576 | 539.822 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 19.802 | 19.078 | 19.157 | 19.157 | 19.17 | 20.156 | 18.156 | 18.156 | 13.125 | 0.002 | 0.002 |
| Retained Earnings
| 1,002.019 | 1,467.63 | 1,381.047 | 1,230.196 | 1,385.441 | 1,245.687 | 1,080.193 | 919.683 | 754.88 | 809.47 | 730.394 |
| Accumulated Other Comprehensive Income/Loss
| 327.35 | 280.316 | 115.793 | 165.176 | 156.322 | 254.609 | 160.355 | 94.506 | 132.432 | -217.339 | -182.272 |
| Other Total Stockholders Equity
| 1,022.97 | 969.665 | 975.319 | 975.319 | 976.807 | 1,126.716 | 717.058 | 717.058 | 6.445 | 78.005 | 78.005 |
| Total Shareholders Equity
| 2,372.141 | 2,736.689 | 2,491.316 | 2,389.848 | 2,537.74 | 2,647.168 | 1,975.762 | 1,749.403 | 906.882 | 957.343 | 877.894 |
| Total Equity
| 2,396.36 | 3,256.522 | 2,957.965 | 2,860.109 | 2,606.093 | 2,687.138 | 2,007.975 | 1,772.318 | 956.145 | 1,006.635 | 916.987 |
| Total Liabilities & Shareholders Equity
| 3,486.854 | 5,380.499 | 4,755.54 | 4,867.15 | 4,580.2 | 4,260.594 | 3,611.155 | 2,970.067 | 1,822.05 | 1,705.211 | 1,456.809 |